- Did not meet target to source 100% of internally procured paper & wood from FSC sources by June 2023 (achieved 66%)
- 17 Lost Time Accidents
Dechra Pharmaceuticals PLC
Greenhouse gas emissions & sustainability report data
In its 2023 reporting, Dechra Pharmaceuticals PLC disclosed greenhouse gas emissions of 157kt CO2e (Scope 1, 2 & 3). Figures are as stated in the company's own report and may use different boundaries, units or methods (for example market-based vs location-based Scope 2), so compare with care.
GHG Emissions
157kt CO2e (Scope 1, 2 & 3)
2023
Water Usage
88.4K m3 (Groundwater/borehole) + 105584 m3 (Municipal supply)
2023
📈 Emissions by Report Period
| Report period | Headline emissions figure reported |
|---|---|
| 2023 | 157kt CO2e (Scope 1, 2 & 3) |
| 2021 | 14.2K tonnes of CO2e |
| 2019-07-01 to 2020-06-30 | 13.4K tCO2e/year |
Each row is the headline figure extracted from a different report; scope coverage and methodology can change between years.
✅ Reported Environmental Achievements
- 13% reduction in GHG emissions intensity ratio
- Reduced waste sent to landfill from 7% to 5%
- 66% FSC paper & wood
- Water withdrawal across manufacturing reduced by 40% (excluding Med-Pharmex)
🎯 Climate & Sustainability Targets
🔜 Short-term
- Eliminate the remaining 34% of suppliers who are non-FSC approved by June 2024
- Zero waste to landfill by 2025
- Transition to electric vehicles by June 2027
- Complete the AUD$6 million investment in AgCoTch by June 2024
🔭 Long-term
- Achieve net zero by 2050
🌱 ESG Focus Areas
Animal Health and WelfareEmissionsLand & water and BiodiversityWage PolicyHuman RightsEquality in the WorkspaceCommunity InvolvementPhilanthropic Activities